MGNet: Exploring Factors Leading to Relapse After B Cell Depletion Therapy in Patients with Myasthenia Gravis
5 de dic. de 2022 ·
2m 11s
Regístrate gratis
Escucha este episodio y muchos más. ¡Disfruta de los mejores podcasts en Spreaker!
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Acta Neuropathologica Communications on October 28, 2022, titled "Reemergence...
mostra más
New research from the Myasthenia Gravis Rare Disease Network (MGNet). This summary is based on a paper published in the journal Acta Neuropathologica Communications on October 28, 2022, titled "Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy."
Read the paper here: https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-022-01454-0
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
mostra menos
Read the paper here: https://actaneurocomms.biomedcentral.com/articles/10.1186/s40478-022-01454-0
Learn more about MGNet: https://mgnet.rarediseasesnetwork.org
Información
| Autor | RDCRN |
| Organización | RDCRN |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
